BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,583,141

« Back to Dashboard

Summary for Patent: 5,583,141

Title: Heterocyclic compounds and their use as angiotensin antagonists
Inventor(s): Naka; Takehiko (Hyogo, JP), Inada; Yoshiyuki (Hyogo, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:08/291,435
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,583,141

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan3-157194Jun 27, 1991
Japan3-188882Jul 29, 1991
Japan3-192054Jul 31, 1991
Japan3-288217Aug 12, 1991
Japan3-239766Sep 19, 1991
Japan3-341107Dec 24, 1991

International Patent Family for Patent: 5,583,141

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria240323► Subscribe
Australia1859892► Subscribe
Australia646343► Subscribe
Canada2072541► Subscribe
China1067890► Subscribe
China1040755► Subscribe
China1079966► Subscribe
China1064044► Subscribe
Germany69233057► Subscribe
Denmark0520423► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Express Scripts
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: